NRx Pharmaceuticals is a clinical-stage biopharmaceutical enterprise focused on developing novel therapeutics targeting central nervous system disorders, treatment-resistant depression, suicidal ideation, and severe respiratory diseases. The company utilizes scientific research platforms to advance pharmaceutical candidates through rigorous clinical trials and regulatory pathways toward commercialization.